APA (7th ed.) Citation

Yu, K., Wu, S., Liu, G., Wu, J., Di, G., Hu, Z., . . . Hou, Y. (2019). Concurrent neoadjuvant chemotherapy and estrogen deprivation in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (CBCSG-036): A randomized, controlled, multicenter trial. Cancer (0008543X), 125(13), 2185. https://doi.org/10.1002/cncr.32057

Chicago Style (17th ed.) Citation

Yu, Ke‐Da, et al. "Concurrent Neoadjuvant Chemotherapy and Estrogen Deprivation in Patients with Estrogen Receptor-positive, Human Epidermal Growth Factor Receptor 2-negative Breast Cancer (CBCSG-036): A Randomized, Controlled, Multicenter Trial." Cancer (0008543X) 125, no. 13 (2019): 2185. https://doi.org/10.1002/cncr.32057.

MLA (9th ed.) Citation

Yu, Ke‐Da, et al. "Concurrent Neoadjuvant Chemotherapy and Estrogen Deprivation in Patients with Estrogen Receptor-positive, Human Epidermal Growth Factor Receptor 2-negative Breast Cancer (CBCSG-036): A Randomized, Controlled, Multicenter Trial." Cancer (0008543X), vol. 125, no. 13, 2019, p. 2185, https://doi.org/10.1002/cncr.32057.